4th Translational Research Conference
Chronic Lymphocytic Leukaemia
Chairs: Jennifer Brown, Paolo Ghia, Michael Hallek

4th Translational Research Conference
Chronic Lymphocytic Leukaemia
Information
ABOUT THE CONFERENCE:
The ESH 4th Translational Research Conference Chronic Lymphocytic Leukaemia proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field. The presentation of new data is encouraged, as well as spirited debates on how to use this knowledge to the future of CLL therapy.
This translational research conference fosters scientific exchange between laboratory scientists and clinicians working on translational CLL research worldwide. It provides opportunities for education and international networking to basic and clinical scientists, including those still in-training.
A first-class selection of international speakers will guarantee the highest quality of science and a summary of the most recent developments in the biology and therapy of CLL.
This educational conference has been approved for 17 CME-CPD credit points by the European Board for Accreditation in Haematology (EBAH)!
SCIENTIFIC TOPICS:
• Spectrum of CLL - one disease or more
• Richter transformation
• Drivers of disease progression
• from genetics, epigenetics, and proteomics (complexity of the evolution)
• The microenvironment of CLL
• Time limited therapies: which combination? which duration? which markers to stop therapy?
• BTK inhibition or degradation?
• The new challenge: resistance to one or two inhibitor classes?
• Double refractory CLL
• Future therapies, new compounds
• Directions and strategies to use the best agents in the optimal way: sequencing, combinations, costs of therapy, availability
Programme
Read the final programme!


